Search
- Feb 1, 2023
- 4 min
Panbela prices $15 million public offering
CPP-1X (eflornithine) is being developed as a single agent tablet or high dose power sachet for several indications including prevention...
- Jan 18, 2023
- 2 min
To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab
The company seeks to achieve U.S. regulatory approval for Bentracimab within the first-half of 2024.
- Jan 10, 2023
- 3 min
Trinity Biotech partners with imaware to deliver diagnostic testing solutions for digital health
imaware’s mission is to empower the health of humanity by providing testing and technology solutions for healing at scale.
- Jan 8, 2023
- 3 min
Global tele-dermatology company MedX Health closes $1.5 million convertible debenture
MedX, y.headquartered in Ontario, Canada, is a leading medical device and software company
- Jan 7, 2023
- 3 min
Retinal Degeneration Fund participates in a $78 million funding round for Perceive Biotherapeutics
AMD is the leading cause of blindness in people 55 and older, affecting more than 150 million people worldwide and 10 million people in US